WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience behavioral testing systems
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 21, 2004, 24(29):6545-6552; doi:10.1523/JNEUROSCI.5760-03.2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Risbrough, V. B.
Right arrow Articles by Geyer, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Risbrough, V. B.
Right arrow Articles by Geyer, M. A.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Corticotropin-Releasing Factor Receptors CRF1 and CRF2 Exert Both Additive and Opposing Influences on Defensive Startle Behavior

Victoria B. Risbrough,1 Richard L. Hauger,2,3 Amanda L. Roberts,4 Wylie W. Vale,5 and Mark A. Geyer1,2,3

Departments of 1Neurosciences and 2Psychiatry, University of California, San Diego, La Jolla, California 92093-0804, 3Veterans Affairs Healthcare System and Department of Psychiatry, University of California, San Diego, La Jolla, California 92093-0603, 4Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037, and 5Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California 92037

The corticotropin-releasing factor (CRF) receptors (CRF1 and CRF2) are crucial mediators of physiological and behavioral responses to stress. In animals, CRF1 appears to primarily mediate CRF-induced anxiety-like responses, but the role of CRF2 during stress is still unclear. Here we report the effects of CRF1 and CRF2 on the magnitude and plasticity of defensive startle responses in mice. Startle plasticity is measured by inhibition of startle by sensory stimuli, i.e., prepulse inhibition (PPI), and is disrupted in patients with panic or posttraumatic stress disorders in which CRF neurotransmission may be overactive. Pharmacological blockade of CRF1 reversed both CRF-induced increases in startle and CRF-induced deficits in PPI. CRF2 blockade attenuated high-dose but not low-dose CRF-induced increases in startle and reduced PPI. Conversely, activation of CRF2 enhanced PPI. CRF had no effect on startle and increased PPI in CRF1 knock-out mice. These data indicate that CRF receptors act in concert to increase the magnitude of defensive startle yet in opposition to regulate the flexibility of startle. These data support a new model of respective CRF receptor roles in stress-related behavior such that, although both receptors enhance the magnitude of defensive responses, CRF1 receptors contravene, whereas CRF2 receptors enhance, the impact of sensory information on defensive behavior. We hypothesize that excessive CRF1 activation combined with reduced CRF2 signaling may contribute to information processing deficits seen in panic and posttraumatic stress disorder patients and support CRF1-specific pharmacotherapy.

Key words: CRH; antisauvagine-30; NBI-30775; R121919; urocortin; anxiety


Received Dec 31, 2003; revised June 7, 2004; accepted June 7, 2004.




This article has been cited by other articles:


Home page
GutHome page
C Wallon, P-C Yang, A V Keita, A-C Ericson, D M McKay, P M Sherman, M H Perdue, and J D Soderholm
Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro
Gut, January 1, 2008; 57(1): 50 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Zhao, G. R. Valdez, E. M. Fekete, J. E. Rivier, W. W. Vale, K. C. Rice, F. Weiss, and E. P. Zorrilla
Subtype-Selective Corticotropin-Releasing Factor Receptor Agonists Exert Contrasting, but Not Opposite, Effects on Anxiety-Related Behavior in Rats
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 846 - 854.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. J. Kang, D. H. Adams, A. Simen, B. B. Simen, G. Rajkowska, C. A. Stockmeier, J. C. Overholser, H. Y. Meltzer, G. J. Jurjus, L. C. Konick, et al.
Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder
J. Neurosci., November 28, 2007; 27(48): 13329 - 13340.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Henry, W. Vale, and A. Markou
The Effect of Lateral Septum Corticotropin-Releasing Factor Receptor 2 Activation on Anxiety Is Modulated by Stress
J. Neurosci., September 6, 2006; 26(36): 9142 - 9152.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-